| · Oxygen supplies (5)
· Community pharmacy
· Vitamin D
· Care homes
· Boots/UniChem merger
· Locum pharmacy
· Assisted dying
· Methadone
· Statins
· CPD
· Criminal convictions
· Overseas pharmacists
· National boards
Letters to the Editor
|
Continuing professional development
In CPD, like regulation, one size does not fit all
From Professor S. J. Mather, FRPharmS
There was an interesting contradiction between the articles by Hemant
Patel, President of the Royal Pharmaceutical Society, and Graham
Phillips,
a member of the Society’s Council, published on consecutive pages
of The Pharmaceutical Journal of 11 February (p185 and p186). On the
one hand Mr Patel is insisting that the Society’s approach to continuing
professional development is appropriate for all pharmacists, whatever
their field of practice; on the other, Mr Phillips criticises the Government
for (perhaps) insisting on a “one size fits all” approach
to professional regulation.
I think few (if any) progressive pharmacists would disagree that keeping
abreast of new developments is an essential part of their job and I,
for one, have no objection to its mandatory introduction. However, I
do object to the imposition of an inflexible, bureaucratic means of recording
CPD activities based on one particular restricted model of learning.
Many of us, working on the fringes of the profession, are in the business
of trying to exploit new scientific discoveries in order to introduce
them into clinical practice. For us, CPD is not an “add-on” activity
but an integral part of our day-to-day work. The “reflective cycle” of
CPD recording that the Society wishes to impose simply does not fit my
job as an academic researcher. I have tried it and, believe me, it does
not.
I can produce evidence (in the form of peer-reviewed publications) that
I am keeping up to date in my chosen field of pharmaceutical practice.
I think the Society must recognise that for CPD, as in professional regulation,
one size does not fit all, and be prepared to accept alternative proofs
of compliance that we are indeed remaining fit to practise in our chosen
specialty.
Stephen J. Mather
Department of Nuclear Medicine,
St Bartholomew’s Hospital,
London
|